It was into up cycle since the AGM. The yearly MA became good support.
broker, MB
Action and recommendation
• Upgrade to Outperform (from Neutral).
Earnings and target price revision
• FY21/22/2 EPS n.m./+24%/+14% driven by cost benefits/ op leverage. PT
upgraded to $20.00 (from $15.30), reflecting earnings changes & reduced
risk discount in FY24 (by 1/3) with vaccine rollout now underway.
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.94 |
Change
-0.195(1.49%) |
Mkt cap ! $2.821B | |||
| Open | High | Low | Value | Volume |
| $13.13 | $13.17 | $12.81 | $9.403M | 727.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2542 | $12.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.94 | 251 | 8 |
View Market Depth
| Last trade - 15.46pm 26/08/2025 (20 minute delay) ? |
| FLT (ASX) Chart |